Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Food Hypersensitivity | 3 | 2024 | 155 | 1.410 |
Why?
|
Sublingual Immunotherapy | 1 | 2023 | 4 | 0.850 |
Why?
|
Job Syndrome | 1 | 2022 | 17 | 0.760 |
Why?
|
Anaphylaxis | 1 | 2022 | 82 | 0.740 |
Why?
|
Peanut Hypersensitivity | 1 | 2022 | 78 | 0.730 |
Why?
|
Eosinophilic Esophagitis | 1 | 2021 | 77 | 0.660 |
Why?
|
Acidosis, Lactic | 1 | 2019 | 30 | 0.630 |
Why?
|
Edema | 1 | 2019 | 137 | 0.600 |
Why?
|
Desensitization, Immunologic | 3 | 2024 | 106 | 0.580 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 260 | 0.570 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 458 | 0.450 |
Why?
|
Infant, Premature | 1 | 2019 | 837 | 0.430 |
Why?
|
Administration, Oral | 3 | 2024 | 700 | 0.400 |
Why?
|
Allergens | 2 | 2023 | 257 | 0.350 |
Why?
|
HIV Infections | 1 | 2019 | 1906 | 0.280 |
Why?
|
Fasciitis | 1 | 2024 | 20 | 0.220 |
Why?
|
Chickens | 1 | 2023 | 635 | 0.200 |
Why?
|
Eosinophilia | 1 | 2024 | 102 | 0.200 |
Why?
|
Arachis | 1 | 2022 | 78 | 0.190 |
Why?
|
Hypersensitivity, Immediate | 1 | 2021 | 16 | 0.190 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2022 | 92 | 0.180 |
Why?
|
Genes, Dominant | 1 | 2022 | 246 | 0.180 |
Why?
|
Abscess | 1 | 2022 | 139 | 0.170 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 146 | 0.170 |
Why?
|
STAT3 Transcription Factor | 1 | 2022 | 219 | 0.170 |
Why?
|
Pneumonia | 1 | 2022 | 325 | 0.150 |
Why?
|
Immunotherapy | 1 | 2022 | 685 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 174 | 0.140 |
Why?
|
Child | 5 | 2024 | 24766 | 0.130 |
Why?
|
Cesarean Section | 1 | 2019 | 393 | 0.130 |
Why?
|
Humans | 9 | 2024 | 126330 | 0.130 |
Why?
|
Quality of Life | 2 | 2024 | 1954 | 0.120 |
Why?
|
Female | 4 | 2024 | 67333 | 0.100 |
Why?
|
Pregnancy | 1 | 2019 | 7257 | 0.070 |
Why?
|
Infant, Newborn | 1 | 2019 | 8308 | 0.060 |
Why?
|
Animals | 1 | 2023 | 34533 | 0.050 |
Why?
|
Methotrexate | 1 | 2024 | 336 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 55 | 0.050 |
Why?
|
Asparaginase | 1 | 2021 | 45 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 173 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 244 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 1909 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 1274 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2021 | 2818 | 0.030 |
Why?
|
Adult | 2 | 2024 | 29802 | 0.020 |
Why?
|
Child, Preschool | 1 | 2024 | 14221 | 0.020 |
Why?
|
Adolescent | 1 | 2024 | 19548 | 0.020 |
Why?
|
Male | 1 | 2024 | 62031 | 0.010 |
Why?
|